PMCK poised for growth with IPO plans
PETALING JAYA: PMCK Bhd, a private healthcare provider enroute to listing on the ACE Market of Bursa Malaysia, intends to pay at least 20% of its net profit as a dividend going forward.
TA Research assumes a dividend payout of 20% to 44% across financial year 2025 (FY25) to FY27 and projects forward yields to be at 1.3% to 2.1%.
TA Research said for its initial public offering (IPO) price of 22 sen a share, PMCK is priced at a trailing price earnings ratio (PE) of 15.9 times based on FY24 earnings per share (EPS).
The research house forecast a target PE of 16 times FY26 EPS for the counter, while deriving a fair value of 23 sen a share.
PMCK is operating the Putra Medical Centre in Alor Setar, Kedah and has been in the business for over 30 years, offering specialist consultant services and clinical support, with 40 consultants across 17 specialisations. PMCK will raise RM60mil through its IPO on Bursa Malaysia.
It wants to strengthen its presence in northern Malaysia to attract patients and drive long-term revenue growth.
Thus far, Kedah has one of the lowest private hospital bed densities in Malaysia, highlighting a significant gap in private healthcare access.
As part of its expansion, PMCK is constructing a new medical centre, PMC Kulim, with operations targeted to start by the first quarter of financial year 2028 (1Q28).
The 12-storey private medical centre comes with a seven-storey mixed development comprising a four-storey hotel with a two-storey food court and carparks.
PMCK will consolidate the RYM DX Laboratory Sdn Bhd (medical lab) into PMC Kulim by 1Q28 to cater to increasing demand for diagnostic services.
It will upgrade the equipment and facilities in PMC Kedah under clinical support services (medical lab) and facilities services (radiology unit).
TA Research projects net profit to contract by 24.8% to RM11.3mil in FY25, as it expects patient numbers to drop by 20% due to the flooding in Alor Setar and surrounding areas, which hindered patient access.
It expects the profit after tax margin to decline to 12.1% (versus 14.4% in FY24) due to softer patient volumes and higher administrative expenses as PMCK's facilities remained fully operational during the heavy rainfall between September and December 2024.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
2 days ago
- The Star
PMCK poised for growth with IPO plans
PETALING JAYA: PMCK Bhd, a private healthcare provider enroute to listing on the ACE Market of Bursa Malaysia, intends to pay at least 20% of its net profit as a dividend going forward. TA Research assumes a dividend payout of 20% to 44% across financial year 2025 (FY25) to FY27 and projects forward yields to be at 1.3% to 2.1%. TA Research said for its initial public offering (IPO) price of 22 sen a share, PMCK is priced at a trailing price earnings ratio (PE) of 15.9 times based on FY24 earnings per share (EPS). The research house forecast a target PE of 16 times FY26 EPS for the counter, while deriving a fair value of 23 sen a share. PMCK is operating the Putra Medical Centre in Alor Setar, Kedah and has been in the business for over 30 years, offering specialist consultant services and clinical support, with 40 consultants across 17 specialisations. PMCK will raise RM60mil through its IPO on Bursa Malaysia. It wants to strengthen its presence in northern Malaysia to attract patients and drive long-term revenue growth. Thus far, Kedah has one of the lowest private hospital bed densities in Malaysia, highlighting a significant gap in private healthcare access. As part of its expansion, PMCK is constructing a new medical centre, PMC Kulim, with operations targeted to start by the first quarter of financial year 2028 (1Q28). The 12-storey private medical centre comes with a seven-storey mixed development comprising a four-storey hotel with a two-storey food court and carparks. PMCK will consolidate the RYM DX Laboratory Sdn Bhd (medical lab) into PMC Kulim by 1Q28 to cater to increasing demand for diagnostic services. It will upgrade the equipment and facilities in PMC Kedah under clinical support services (medical lab) and facilities services (radiology unit). TA Research projects net profit to contract by 24.8% to RM11.3mil in FY25, as it expects patient numbers to drop by 20% due to the flooding in Alor Setar and surrounding areas, which hindered patient access. It expects the profit after tax margin to decline to 12.1% (versus 14.4% in FY24) due to softer patient volumes and higher administrative expenses as PMCK's facilities remained fully operational during the heavy rainfall between September and December 2024.
The Star
2 days ago
- The Star
Oil prices capped despite geopolitical conflict
TA Research has retained its 'neutral' view on the O&G sector. PETALING JAYA: Any further upside to the price premium of crude oil prices fuelled by the Iran-Israel conflict is constrained by ample spare capacity among Organisation of the Petroleum Exporting Countries and its members (Opec) members as well as non-Opec suppliers, TA Research states in its oil and gas (O&G) sector report. It said global demand for energy also remains weaker due to slower economic activity and the increased use of electric vehicles. The research house added the geopolitical premium put on crude oil prices since the conflict erupted is more likely to be transient rather than transformative. 'The global oil supply backdrop remains relatively resilient despite the geopolitical turmoil. Opec, led by Saudi Arabia, holds sufficient spare production capacity to offset most short term disruptions from Iran,' it stated. TA Research added US shale producers continue to deliver robust output levels, averaging a steady 13.4 million barrels per day while other non-Opec producers like Brazil, Canada, and Guyana are also ramping up supply, contributing to a broader narrative of a well-supplied global market. While supply-side fears can generate temporary price rallies, the demand picture remains insufficiently supportive for a sustained oil bull cycle without further macroeconomic improvement, TA Research opined. 'While the war may add volatility, the probability of a sustained supply shock remains relatively low unless additional producers or infrastructure become targets,' it summarised. Hence, TA Research has maintained its average Brent crude oil price forecast of US$73 a barrel for 2025. 'We retain our 'neutral' view on the O&G sector, as we believe the risk-reward balance remains evenly poised. 'We reiterate our preference for oil and gas players with strong export linkages and robust cash generation, such as Pantech Group Holdings Bhd and MISC Bhd ,' the research house noted. It explained that MISC ('buy', target price: RM8.40) stands to benefit from increased demand for tanker freight and floating solutions, particularly as shipping markets remain volatile. Additionally, Pantech ('buy', target price: 96 sen), meanwhile, is well placed to ride on higher project flows for pipeline and industrial fittings, driven by infrastructure upgrades and intensified maintenance cycles in response to supply chain vulnerabilities. That said, TA Research said should diplomacy prevail and the war drums go quiet, it forecasts crude oil prices to correct to US$60 to US$65 a barrel level for the Brent contract. Furthermore, should there be complications in the Straits of Hormuz which disrupt supply lines out of the region, prices could spike to US$100 to US$120 a barrel levels.
The Star
13-06-2025
- The Star
Binastra's order book continues to strengthen
PETALING JAYA: A recent contract win by construction group Binastra Corp Bhd could contribute about RM16.1mil in net profit over the building period for the project, analysts say. This is based on an assumption of a net margin of 6%, said TA Research and Phillip Capital Research. The group secured a RM268mil contract from TNJ Development Sdn Bhd, a subsidiary of CPI Land, for the main building work for the Tuan Heritag3 Residency condominium development in Segambut, Kuala Lumpur, with a gross development value (GDV) of RM670mil. However, Phillip Capital Research said this is lower than the historical average of between 9% and 10%, reflecting a greater reliance on subcontracting as Binastra preserves internal capacity for its expanding pipeline of projects in Johor. The research house remained positive about the prospects for the group's order book replenishment, supported by up toRM7bil of committed project launches from major clients in Johor, scheduled from 2026 to 2027. The research house said it was encouraged by this latest contract win, which not only strengthened the group's order book but also brings in a new client that intends to launch projects with GDVs of RM1bil in this year and exploring expansion opportunities into Johor. The research house believes this could pave the way for future project wins. The award brings year-to-date job wins to RM976.9mil, representing 28% of its RM3.5bil order book replenishment assumption for 2026. This raises Binastra's order book to RM4.3bil, implying a 4.5 times cover of its revenue for this year. TA Research said it believes the group is well-positioned to secure additional contracts from CPI Land's RM1bil GDV pipeline. RHB Research said the group's order book is worth RM4.3bil and provides earnings visibility for the next four years. The research house said it believes Binastra's likely job wins will come from the southern region. For instance, one of Binastra's clients, Exsim Development Sdn Bhd, has a few other land parcels in Johor Baru near the New York Hotel and along Jalan Lumba Kuda, and projects there could have a cumulative GDV of over RM3bil or a potential construction value that may exceed RM1.5bil. Maxim Global Bhd , another key client, has acquired a 6.5 acre plot of land in Taman Pelangi for future development. TA Research, Phillip Capital Research and RHB Research maintained their 'buy' calls on the stock with target prices of RM2.39, RM2.30 and RM2.21, respectively. Both Phillip Cpital Research and RHB Research made no changes to their earnings estimates with the latest job win.
